Advertisement

Dye—Light Phototherapy of Viral Bacterial, and Fungal Infections

  • M. Jarratt
  • W. HublerJr.
  • W. Panek
Part of the Photobiology book series (PB)

Abstract

In 1899 Oscar Raab (1), a student in Dr. H. von Tappeiner’s Munich laboratory, observed that paramecia were killed in the presence of acridine dye and light but were unharmed in the presence of acridine dye in the dark. During the next few years of the early 20th century, von Tappeiner and Jodlbauer (2–4) conducted a long series of experiments with the dye-light reaction and coined the term “photodynamische erscheinung” (photodynamic action). They demonstrated that many dyes photosensitize a wide variety of microorganisms in vitro (Fig. 20–1).

Keywords

Herpes Simplex Virus Methylene Blue Herpes Simplex Virus Type Herpes Simplex Virus Encephalitis Bacillus Anthracis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Raab, O. (1900): Ueber die Wirkung Huoreseierender Stoffe und Infusorien. Z. Biol. 39:524–526.Google Scholar
  2. 2.
    von Tappeiner, H., and Jodlbauer, A. (1904): Ueber die Wirkung der photodynamishen Stoffe auf Protozoen und Enzyme. Dtsch. Arch. Klin. Med. 80:427.Google Scholar
  3. 3.
    von Tappeiner, H., and Jodlbauer, A. (1907): Die sensibilisierende Wirkung Fluorescier-ender Substanzen. Vogel, Leipzig.Google Scholar
  4. 4.
    von Tappeiner, H. (1909): Die photodynamische Erscheinung (Sensibilisierung durch fluoressierende Stoffe). Ergeb. Physiol. 8:698–741.CrossRefGoogle Scholar
  5. 5.
    Chavarria, A. P., and Clark, J. H. (1924): The reaction of pathogenic fungi to ultraviolet light. Am. J. Hygiene 4:639–649.Google Scholar
  6. 6.
    Clifton, C. E. (1931): Photodynamic action of certain dyes on the inactivation of Staphylococcus bacteriophage. Proc. Soc. Exp. Biol. Med. 28:745–746.Google Scholar
  7. 7.
    Perdrau, J. R., and Todd, C. (1933): The photodynamic action of methylene blue on certain viruses. Proc. R. Soc. Lond. 112:288–298.CrossRefGoogle Scholar
  8. 8.
    Orlob, G. B. (1967): Inactivation of purified plant viruses and their nucleic acids by photosensitizing dyes. Virology 31:402–413.PubMedCrossRefGoogle Scholar
  9. 9.
    Hessler, A. Y. (1965): Acridine resistance in bacteriophage T2H as a function of dye penetration measured by mutagenesis and photoinactivation. Genetics 52:711–722.PubMedGoogle Scholar
  10. 10.
    Wallis, C., and Melnick, J. L. (1965): Photodynamic inactivation of animal viruses. Photochem. Photobiol. 41:159–170.CrossRefGoogle Scholar
  11. 11.
    Wallis, C., and Melnick, J. L. (1965): Photodynamic inactivation of enteroviruses. J. Bacteriol. 89:41–46.PubMedGoogle Scholar
  12. 12.
    Felber, T. D., Smith, E. B., Knox, J. M., et al. (1973): Photodynamicinactivationofherpes simplex. J. AMA 223:289–292.Google Scholar
  13. 13.
    Kaufman, R. H., Gardner, H. L., Brown, D., et al. (1973): Herpes genitalis treated by photodynamic inactivation of virus. Obstet. Gynecol. 117:1144–1146.Google Scholar
  14. 14.
    Lefebvre, E. B., and McNellis, E. E. (1973): Photoinactivation of herpes simplex. J. AMA 224:1039.Google Scholar
  15. 15.
    Hinthorne, D. R., Baker, L. H., Romig, D. A., et al. (1976): Recurrent conjugal neuralgia caused byHerpesvirus hominis type 2. J. AMA 236:587–588.Google Scholar
  16. 16.
    Rubin, M. B., and Heaton, C. L. (1972): Phototherapy of recurrent cutaneous Herpesvirus hominis infection with acridine orange and ultraviolet light. In: Proceedings of the 14th International Congress of Dermatology, Padua-Venice, May 22–27, pp. 162–166.Google Scholar
  17. 17.
    Chang, T., Weinstein, L. (1975): Eczema herpeticum: treatment with methylene blue and light. Arch. Dermatol. 111:1174–1175.PubMedCrossRefGoogle Scholar
  18. 18.
    Moore, C., Wallis, C., Melnick, J. L., et al. (1972): Photodynamic treatment of herpes keratitis. Infect. Immun. 5:169–171.PubMedGoogle Scholar
  19. 19.
    Lanjer, J. D., Witcher, J. P., and Dawson, C. R. (1973): Proflavineand light in the treatment of experimental herpetic keratitis (abstract). Symp. Assoc. Res. Vis. Ophthalmol., p. 51.Google Scholar
  20. 20.
    Tara, C. S., Stanley, J. A., Kucera, L. J., et al. (1974): Photodynamic inactivation of herpes simplex keratitis. Arch. Ophthalmol. 92:51–53.PubMedCrossRefGoogle Scholar
  21. 21.
    Lahav, M., Dueker, D., Bhatt, P. N., et al. (1975): Photodynamic inactivation in experimental herpetic keratitis. Arch. Ophthalmol. 93:207–214.PubMedCrossRefGoogle Scholar
  22. 22.
    O’Day, D. M., Jones, B. R., Poirier, R., et al. (1975): Proflavine photodynamic viral inactivation in herpes simplex keratitis. Am. J. Ophthalmol. 79:941–948.PubMedGoogle Scholar
  23. 23.
    Myers, M. G., Oxman, M. N., Clark, J. E., et al. (1975): Failure of neutral red photodynamic inactivation in recurrent herpes simplex infections. N. Engl. J. Med. 293:945–949.PubMedCrossRefGoogle Scholar
  24. 24.
    Taylor, P. K., and Doherty, N. R. (1975): Comparison of the treatment of herpes genitalis in men with proflavine photoinactivation, idoxuridine ointment and normal saline. Br. J. Vener. Dis. 51:125–129.PubMedGoogle Scholar
  25. 25.
    Roome, A. P., Tinkler, A. E., Hilton, A. L., et al. (1975): Neutralred with photoinactivation in the treatment of herpes genitalis. Br. J. Vener. Dis. 51:130–133.PubMedGoogle Scholar
  26. 26.
    Kaufman, R. H., Adam, E., Mirkovic, R. R., et al. (1978): Treatment of genital herpes simplex virus infection with photodynamic inactivation. Am. J. Obstet. Gynecol. 132: 861–869.PubMedGoogle Scholar
  27. 27.
    Rapp, F. (1973): Medical News: Photoinactivation of herpesvirus may be clinically hazardous. J. AMA 255:459–460.Google Scholar
  28. 28.
    Duff, R., and Rapp, F. (1971): Oncogenic transformation of hamster cells after exposure to herpes simplex virus type 2. Nature [New Biol] 233:48.CrossRefGoogle Scholar
  29. 29.
    Rapp, F., Li, J. H., and Jerkofsky, M. (1973): Transformation of mammalian cells by DNA-containing viruses following photodynamic inactivation. Virology 55:339–346.PubMedCrossRefGoogle Scholar
  30. 30.
    Li, J. L., Jerkofsky, M. A., and Rapp, F. (1975): Demonstration of oncogenic potential of mammalian cells transformed by DNA-containing viruses following photodynamic inactivation. Int. J. Cancer 15:190–202.PubMedCrossRefGoogle Scholar
  31. 31.
    Verwoerd, D. W., and Rapp, F. (1978): Biochemical transformation of mouse cells by herpes simplex virus type 2: enhancement by means of low-level photodynamic treatment. J. Virol. 26:200–202.PubMedGoogle Scholar
  32. 32.
    Berger, R. S., and Papa, C. M. (1977): Photodye herpes therapy—Cassandra confirmed? J. AMA 238:133–134.Google Scholar
  33. 33.
    Berger, B. W., and Hori, Y. (1978): Multicentric Bowen’s disease of the genitalia. Arch. Dermatol. 114:1698–1699.PubMedCrossRefGoogle Scholar
  34. 34.
    Wade, T. R., Kopf, A. W., and Ackerman, A. B. (1979): Bowenoid papulosis of the genitalia. Arch. Dermatol. 115:306–308.PubMedCrossRefGoogle Scholar
  35. 35.
    Wade, T. R., and Ackerman, A. B. (1977): Squamous cell carcinoma in-situ: multiple lesions on the penis in young men. Arch. Dermatol. 113 1714.Google Scholar
  36. 36.
    Lupulescu, A., Mehregan, A. H., Rahbari, H., et al. (1977): Venereal warts vs Bowen disease. J. AMA 237:2520–2522.Google Scholar
  37. 37.
    Friedrich, E. G. (1972): Reversible vulvar atypia. Obstet. Gynecol. 39:173–181.PubMedGoogle Scholar
  38. 38.
    Kopf, A. W., Ackerman, A. B., Wade, T., et al. (1978): Photodye herpes therapy. J. AMA 239:615.Google Scholar
  39. 39.
    Browning, C. H., and Gilmore, W. (1913): Bacteriocidal action and chemical constitution with special reference to basic benzol derivatives. J. Pathol. BacterioI. 18 144–146.Google Scholar
  40. 40.
    Albert, A. (1966): The Acridines, 2nd ed. Edward Arnold, London.Google Scholar
  41. 41.
    Mitchell, G. A. G., and Buttler, G. A. H. (1943): Proflavine in closed wounds. Lancet 2:749.CrossRefGoogle Scholar
  42. 42.
    Rank, B. K. (1944): Use and abuse of local antiseptics on wounds. Med. J. Aust. 2:629–636.Google Scholar
  43. 43.
    Albert, A., Rubbo, S. D., and Maxwell, M. (1942): The influence of chemical constitution on antiseptic activity. I. Study of the mono-amino acridines. Br. J. Exp. Pathol. 23:69–83.Google Scholar
  44. 44.
    Rubbo, S. D., Albert, R. J., Goldacre, M. E., et al. (1945): The influence of chemical constitution on antibacterial activity II: A general survey of the acridine series. Br. J. Exp. Pathol. 26:160–192.Google Scholar
  45. 45.
    Gordon, J., McLeod, J. W., and Mayr-Harting, A. (1947): The value of antiseptics as prophylactic applications to recent wounds. J. Hyg. (Camb.) 45:297–306.CrossRefGoogle Scholar
  46. 46.
    Heinmets, F., Vinegar, R., and Taylor, W. W. (1953): Studies on the mechanisms of the photosensitized inactivation of E. coli and reactivation phenomenon. J. Gen. Physiol. 36:207–226.CrossRefGoogle Scholar
  47. 47.
    Wallis, C., Melnick, J. L., and Phillips, C. A. (1965): Bacterial and fungal decontamination of virus specimens by differential photosensitization. Am. J. Epidemiol. 81:222–229.PubMedGoogle Scholar
  48. 48.
    Cooney, J. J., and Krinsky, N. I. (1972): Photodynamic killing of Acholeplasma laidlawii. Photochem. Photobiol. 16:523–526.CrossRefGoogle Scholar
  49. 49.
    Dickey, R. F. (1962): Investigative studies in fungicidal powers of photodynamic action. J. Invest. Dermatol. 39:7–19.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • M. Jarratt
    • 1
  • W. HublerJr.
    • 1
  • W. Panek
    • 1
  1. 1.Department of DermatologyBaylor College of MedicineHoustonUSA

Personalised recommendations